MYT NETHERLANDS PARENT BV (MYTE) Stock Fundamental Analysis
USA - NYSE:MYTE - US55406W1036 - ADR
7.64 USD
-0.2 (-2.55%)
Overall MYTE gets a fundamental rating of 3 out of 10. We evaluated MYTE against 123 industry peers in the Specialty Retail industry. The financial health of MYTE is average, but there are quite some concerns on its profitability. MYTE is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year MYTE was profitable.
MYTE had a negative operating cash flow in the past year.
In the past 5 years MYTE reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: MYTE reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -5.01%, MYTE is not doing good in the industry: 68.85% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -8.64%, MYTE is in line with its industry, outperforming 42.62% of the companies in the same industry.
The Return On Invested Capital of MYTE (0.05%) is worse than 63.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.01% | ||
| ROE | -8.64% | ||
| ROIC | 0.05% |
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MYTE has a Operating Margin of 0.03%. This is in the lower half of the industry: MYTE underperforms 63.93% of its industry peers.
Looking at the Gross Margin, with a value of 47.04%, MYTE is in the better half of the industry, outperforming 72.13% of the companies in the same industry.
MYTE's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.03% | ||
| PM (TTM) | N/A | ||
| GM | 47.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MYTE is destroying value.
MYTE has more shares outstanding than it did 1 year ago.
MYTE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MYTE has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.23 indicates that MYTE is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.23, MYTE belongs to the top of the industry, outperforming 86.07% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that MYTE is not too dependend on debt financing.
The Debt to Equity ratio of MYTE (0.19) is better than 61.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.23 |
ROIC/WACC0.01
WACC7.41%
2.3 Liquidity
MYTE has a Current Ratio of 1.78. This is a normal value and indicates that MYTE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.78, MYTE is doing good in the industry, outperforming 76.23% of the companies in the same industry.
A Quick Ratio of 0.22 indicates that MYTE may have some problems paying its short term obligations.
The Quick ratio of MYTE (0.22) is worse than 85.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 0.22 |
3. Growth
3.1 Past
MYTE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 525.00%, which is quite impressive.
MYTE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.84%.
MYTE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.27% yearly.
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%
3.2 Future
MYTE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.63% yearly.
Based on estimates for the next years, MYTE will show a quite strong growth in Revenue. The Revenue will grow by 9.58% on average per year.
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 27.29, which means the current valuation is very expensive for MYTE.
Compared to the rest of the industry, the Price/Earnings ratio of MYTE is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.30, MYTE is valued at the same level.
MYTE is valuated rather expensively with a Price/Forward Earnings ratio of 18.32.
MYTE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MYTE is cheaper than 61.48% of the companies in the same industry.
MYTE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.29 | ||
| Fwd PE | 18.32 |
4.2 Price Multiples
67.21% of the companies in the same industry are cheaper than MYTE, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 49.69 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MYTE's earnings are expected to grow with 54.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y115.23%
EPS Next 3Y54.63%
5. Dividend
5.1 Amount
MYTE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:MYTE (4/30/2025, 8:23:38 PM)
7.64
-0.2 (-2.55%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner Change5.46%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.04B
Analysts76.36
Price Target10.71 (40.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.51%
Min EPS beat(2)96.08%
Max EPS beat(2)206.95%
EPS beat(4)2
Avg EPS beat(4)50.27%
Min EPS beat(4)-50.98%
Max EPS beat(4)206.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-3.03%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-0.99%
Revenue beat(12)4
Avg Revenue beat(12)-1.89%
Revenue beat(16)7
Avg Revenue beat(16)-0.73%
PT rev (1m)0%
PT rev (3m)49.57%
EPS NQ rev (1m)-140.01%
EPS NQ rev (3m)-111.77%
EPS NY rev (1m)0%
EPS NY rev (3m)17.95%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.29 | ||
| Fwd PE | 18.32 | ||
| P/S | 1.05 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.23 | ||
| P/tB | 3.57 | ||
| EV/EBITDA | 49.69 |
EPS(TTM)0.28
EY3.66%
EPS(NY)0.42
Fwd EY5.46%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS7.27
BVpS3.42
TBVpS2.14
PEG (NY)0.09
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.01% | ||
| ROE | -8.64% | ||
| ROCE | 0.06% | ||
| ROIC | 0.05% | ||
| ROICexc | 0.05% | ||
| ROICexgc | 0.07% | ||
| OM | 0.03% | ||
| PM (TTM) | N/A | ||
| GM | 47.04% | ||
| FCFM | N/A |
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score3
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.11 | ||
| Cap/Depr | 47.13% | ||
| Cap/Sales | 1.02% | ||
| Interest Coverage | 0.05 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 0.22 | ||
| Altman-Z | 4.23 |
F-Score3
WACC7.41%
ROIC/WACC0.01
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
EBIT growth 1Y101.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.35%
EBIT Next 3Y67.88%
EBIT Next 5YN/A
FCF growth 1Y18.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-407.95%
OCF growth 3YN/A
OCF growth 5Y33.41%